TwinStrand Biosciences: Gary Gilliland

Gary Gilliland has been appointed to the board of directors of Seattle-based TwinStrand Biosciences. Until February 2020, he was the president and director of the Fred Hutchinson Cancer Research Center. Prior to that, he was a professor at Harvard Medical School, director of the leukemia program at the Dana-Farber Cancer Institute, senior VP and global oncology franchise head at Merck, and vice dean of the Perlman School of Medicine at the University of Pennsylvania. Gilliland holds an MD from the University of California, San Francisco, and a PhD in microbiology from the University of California, Los Angeles.